Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ATLAS AIR WORLDWIDE HOLDINGS INCAAWW · Entity 115323 | Director | May 31, 2022 | June 02, 2022 |
| Celanese CorpCE · Entity 3922 | Director | May 10, 2021 | May 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ATLAS AIR WORLDWIDE HOLDINGS INC
Report date May 31, 2022 · Filed June 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 7,852 |
Ending reported balance
After 2022-05-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-05-31 · Grant · Acquired 1,620 · Balance 5,025 Row 2 · 2022-05-31 · Grant · Acquired 2,827 · Balance 7,852 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-31 · Exercise / conversion · Disposed 1,620 · Balance 0 F1: Upon vesting, the Reporting Person is entitled to receive one share of Common Stock for each restricted stock unit. F2: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). Vesting of all or a portion of the units may be deferred to a date on which the Reporting Person is separated from Board service or a date specified by the Reporting Person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-31 · Exercise / conversion · Disposed 2,827 · Balance 0 F1: Upon vesting, the Reporting Person is entitled to receive one share of Common Stock for each restricted stock unit. F2: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). Vesting of all or a portion of the units may be deferred to a date on which the Reporting Person is separated from Board service or a date specified by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon vesting, the Reporting Person is entitled to receive one share of Common Stock for each restricted stock unit.
F2: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). Vesting of all or a portion of the units may be deferred to a date on which the Reporting Person is separated from Board service or a date specified by the Reporting Person.
Celanese Corp
Report date May 10, 2021 · Filed May 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 20,341.515 |
Reported balance
After 2021-05-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-05-10 · Grant · Acquired 82.394 · Balance 20,341.515 F1: Each share of phantom stock represents the right to receive one share of Common Stock. F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock represents the right to receive one share of Common Stock.
F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LANXESS Solutions US Inc.
Report date April 21, 2017 · Filed April 24, 2017
Section 16 reporting ended · disclosed 2017-04-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-21 transaction · row 1
1 source rowRow 1 · 2017-04-21 · Disposition to issuer · Disposed 54,898 · Balance 0 F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2019 Filed Apr 29, 2019 16:16 UTC | Celanese Corp CE · Entity 3922 | SaleCommon Stock | 9,175 | $108.32 | $993,810.31 |
DisclosureSEC source: 0001306830-19-000119 · wf-form4_155656900302906.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,872 F1 · price: The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $108.070 to $108.990. The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:12 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 93.817 | $102.80 | $9,644.39 |
DisclosureSEC source: 0001306830-19-000058 · wf-form4_155182033663629.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,953.887 Underlying: Common Stock · 93.817 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 08:45 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 91.451 | $104.92 | $9,595.04 |
DisclosureSEC source: 0001306830-18-000253 · wf-form4_154211670881130.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,860.07 Underlying: Common Stock · 91.451 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 06, 2018 Filed Aug 7, 2018 16:31 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 81.911 | $116.60 | $9,550.82 |
DisclosureSEC source: 0001306830-18-000186 · wf-form4_153367384608252.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,768.619 Underlying: Series A Common Stock · 81.911 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 23, 2018 Filed May 25, 2018 14:28 UTC | ATLAS AIR WORLDWIDE HOLDINGS INC AAWW · Entity 115323 | GrantRestricted Stock Units · Derivative | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033453 · doc4.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,620 Underlying: Common Stock · 1,620 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, the Reporting Person is entitled to receive one share of Common Stock for each restricted stock unit. F2 · derivative.exercise_date: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). F2 · derivative.expiration_date: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). Read SEC document |
| May 10, 2018 Filed May 14, 2018 17:12 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 86.715 | $109.60 | $9,503.96 |
DisclosureSEC source: 0001306830-18-000144 · wf-form4_152633230286694.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,686.708 Underlying: Series A Common Stock · 86.715 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 04, 2018 Filed May 7, 2018 17:19 UTC | ATLAS AIR WORLDWIDE HOLDINGS INC AAWW · Entity 115323 | SaleCommon Stock, $0.01 par value | 7,500 | $65.21 | $489,097.50 |
DisclosureSEC source: 0001209191-18-028385 · doc4.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,979 F1 · price: These shares were sold at an average of $65.213. Prices ranged from $65.20 to $65.35. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 16:44 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-18-000127 · wf-form4_152460265979690.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,047 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as amended and restated. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:38 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 77.039 | $104.63 | $8,060.59 |
DisclosureSEC source: 0001306830-18-000063 · wf-form4_152037227765171.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,599.993 Underlying: Series A Common Stock · 77.039 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:58 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 76.483 | $104.93 | $8,025.36 |
DisclosureSEC source: 0001306830-17-000251 · wf-form4_151061029294715.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,522.954 Underlying: Series A Common Stock · 76.483 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| October 24, 2017 Filed Oct 25, 2017 16:45 UTC | Celanese Corp CE · Entity 3922 | GiftSeries A Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000239 · wf-form4_150896433313652.xml · nonDerivative · entry 2 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,675 Read SEC document |
| October 24, 2017 Filed Oct 25, 2017 16:45 UTC | Celanese Corp CE · Entity 3922 | SaleSeries A Common Stock | 2,500 | $105.88 | $264,693.25 |
DisclosureSEC source: 0001306830-17-000239 · wf-form4_150896433313652.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,175 F1 · price: The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $105.8769 to $105.88. The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 16:38 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 80.868 | $98.78 | $7,988.14 |
DisclosureSEC source: 0001306830-17-000201 · wf-form4_150222471041416.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,446.471 Underlying: Series A Common Stock · 80.868 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 24, 2017 Filed May 25, 2017 18:36 UTC | ATLAS AIR WORLDWIDE HOLDINGS INC AAWW · Entity 115323 | GrantRestricted Stock Units · Derivative | 2,261 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035574 · doc4.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261 Underlying: Common Stock · 2,261 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, the Reporting Person is entitled to receive one share of Common Stock for each restricted stock unit. F2 · derivative.exercise_date: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). F2 · derivative.expiration_date: The units vest in their entirety on the first to occur of the following: the first anniversary of the date of grant; the day of the Reporting Person's death; the day of the Reporting Person's disability (as defined); or a Change in Control of the Company (as defined). Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:09 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 92.392 | $86.00 | $7,945.71 |
DisclosureSEC source: 0001306830-17-000157 · wf-form4_149461977959665.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,365.603 Underlying: Series A Common Stock · 92.392 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 09:04 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Disposition to issuerCommon Stock | 54,898 | $33.50 | $1,839,083.00 |
DisclosureSEC source: 0000899243-17-010781 · doc4.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 16:38 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000146 · wf-form4_149306631135340.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,675 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as Amended and Restated February 9, 2017. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:58 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 68.825 | $89.99 | $6,193.56 |
DisclosureSEC source: 0001306830-17-000090 · wf-form4_148892390243587.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,273.211 Underlying: Series A Common Stock · 68.825 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:05 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | GrantCommon Stock | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006340 · doc4.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,898 F1 · shares: Grant of shares under the Chemtura Corporation Annual Equity Grant for non-employee directors. Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 16:15 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | GiftCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-034980 · doc4.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,886 Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 17:54 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 80.803 | $76.29 | $6,164.46 |
DisclosureSEC source: 0001306830-16-000439 · wf-form4_147916405349532.xml · derivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,204.386 Underlying: Series A Common Stock · 80.803 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 17:59 UTC | ATLAS AIR WORLDWIDE HOLDINGS INC AAWW · Entity 115323 | Exercise / conversionRestricted Stock Units · Derivative | 2,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-142304 · doc4.xml · derivative · entry 2 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,479 shares Expires 2016-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These restricted stock units vested on September 20, 2016 in connection with the approval by the issuer's shareholders of the "Restricted Share Issuance" as described in the issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, on August 12, 2016 and were converted into an equivalent number of shares of Common Stock. F1 · derivative.exercise_date: These restricted stock units vested on September 20, 2016 in connection with the approval by the issuer's shareholders of the "Restricted Share Issuance" as described in the issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, on August 12, 2016 and were converted into an equivalent number of shares of Common Stock. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 17:59 UTC | ATLAS AIR WORLDWIDE HOLDINGS INC AAWW · Entity 115323 | GrantCommon Stock, $0.01 par value | 2,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-142304 · doc4.xml · nonDerivative · entry 1 WULFF JOHN K · CIK 0001257328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,479 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.